Abbott
At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life. Today, 73,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.
Business & Industry
- Merck and Pfizer provide update on avelumab in platinum-resistant/refractory ovarian cancer
- MSD is looking for a digital health solution to empower oncologists by keeping them updated in their field
- Lilly submits New Drug Application to the FDA for lasmiditan for acute treatment of migraine, receives Breakthrough Therapy Designation for Emgality™ (galcanezumab-gnlm) for prevention of episodic cluster headache
- Abbott recommends rejection of below-market mini-Ttender offer by Baker Mills LLC
- AstraZeneca to divest US Synagis rights to Sobi
Research & Development
- Aspirin and omega-3 reduce pre-cancerous bowel polyps
- Scorpion venom to shuttle drugs into the brain
- Patient engagement as a new blockbuster drug, not quite yet, study finds
- Obesity both feeds tumors and helps immunotherapy kill cancer
- Blue light can reduce blood pressure
- Gap in research means millions living with long-term consequences of cancer
- Tumour immune cells could aid cancer therapies
Conferences & Events
- 21st Annual Superbugs & Superdrugs Conference
- SMi Group announces the 10th Annual RNA Therapeutics Conference
- Pre-Filled Syringes & Injectable Drug Devices Europe 2018
- Social Media in the Pharmaceutical Industry Conference 2019
- Lyophilization USA Conference 2018
- SMi presents the 13th annual industry leading conference: Cold Chain Distribution
- Orphan Drugs and Rare Diseases Conference 2018
Regulatory Affairs
- FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot
- FDA highlights record-breaking number of generic drug approvals in October
- FDA approves new drug to treat influenza
- FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs
- FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old